Several in silico studies have investigated the perturbation of MASTL through a network biology approach, highlighting a potential therapeutic benefit from MASTL inhibition in neuroblastoma [46] and supporting investigations in breast cancer [15]. Here, MASTL is linked to breast carcinoma.